What We Still Dont Know There are still major gaps in what we know about TB-500 in humans, including long-term safety, effects of repeated use, and impact across different populations over time
Those with cardiovascular disease, renal impairment, or haematological disorders should seek medical advice before commencing treatment
[] Recent breakthroughs in elucidating the molecular mechanisms underlying obesity, including central appetite regulation, adipose tissue metabolism, and gutbrain communication, have unveiled novel therapeutic targets
Because deficiency-related treatment is rarely a one-time fix and often needs a course of injections spread across weeks, the demand for Methylcobalamin tends to be steady and repeat-driven rather than a one-off purchase
We provide the suitability data to customers for transparency and so they can be confident in the results
The absence of data on long-term and high-dose effects requires medical supervision